CEA-targeted CAR-T cells: Clinical Trials

6 trials of CEA-targeted CAR-T cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 completed, 1 unknown. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 4, Completed 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow CEA-targeted CAR-T cells: new trials by email Literature Review of CEA-targeted CAR-T cells trials Research Report on CEA-targeted CAR-T cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
CEA-targeted CAR-T cells - Peritoneal Metastases From Colorectal Cancer
Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine122025-11-032025-11-25
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
CEA-targeted CAR-T cells - Lung Cancer, Gastric Cancer
Phase 1RecruitingChongqing Precision Biotech Co., Ltd1082025-09-122025-10-02
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
CEA-targeted CAR-T cells - Gastric Cancer, Colon Cancer
Phase 1RecruitingChongqing Precision Biotech Co., Ltd602023-11-062023-11-13
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
CEA-targeted CAR-T cells - Gastric Cancer, Colon Cancer
Phase 1 / Phase 2UnknownChongqing Precision Biotech Co., Ltd602023-09-072024-08-09
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
CEA-targeted CAR-T cells - Colorectal Cancer, Esophagus Cancer
Phase 1RecruitingChongqing Precision Biotech Co., Ltd302023-08-112023-09-21
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
CEA-targeted CAR-T cells - Gastric Cancer, Colon Cancer
Phase 1 / Phase 2CompletedChongqing Precision Biotech Co., Ltd172022-06-072026-07-10

Conditions studied

Esophageal Neoplasms (5)  ·  Pancreatic Neoplasms (5)  ·  Stomach Neoplasms (5)  ·  Colonic Neoplasms (4)  ·  Rectal Neoplasms (4)  ·  Breast Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Colorectal Neoplasms (1)

Sponsors

Chongqing Precision Biotech Co., Ltd (5)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (6)

Top investigators

Donglai Lv, MD (1)  ·  Jia Wei, M.D (1)  ·  Lifeng Sun (1)  ·  Ning Li, MD (1)  ·  Qi Mei, M.D (1)  ·  Shuang Wei, M.D (1)  ·  Weijia Fang, M.D (1)  ·  Ying Yuan (1)  ·  Ying Yuan, M.D (1)